UnitedHealth Group is a leading diversified health and well-being company that provides a wide range of health care products and services. The company operates through two main segments: UnitedHealthcare, which offers health insurance and health services to individuals and businesses, and Optum, which delivers pharmacy care, health management, and technology solutions. UnitedHealth Group focuses on enhancing health care access, improving health outcomes, and optimizing costs through integrated care solutions and data-driven insights. With a commitment to innovation and quality, the company aims to help people live healthier lives while making the health care system work better for everyone. Read More
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.
The FTC has paused its antitrust case against major PBMs, citing a lack of commissioners. The lawsuit alleges unfair practices that inflated insulin prices.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Elevance Health (NYSE:ELV) and the rest of the health insurance providers stocks fared in Q4.
Although the S&P 500 is down 1.7% over the past six months, UnitedHealth’s stock price has fallen further to $523.02, losing shareholders 10.3% of their capital. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Knowing which stocks to hold for the long term and which to sell before they drag down your portfolio is a challenge every investor faces at least once in their journey.
NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.
In a market obsessed with the next big growth story, it’s easy to overlook the quiet power of consistency. As tariff turbulence continues, some investors are diverting a portion of their portfolio funds to dividend stocks, which both provide immediate income and traditionally show less volatility compared to stocks that do not pay dividends.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Cencora (NYSE:COR) and its peers.
UnitedHealth Group (NYSE: UNH) will release its first quarter 2025 financial results on Thursday, April 17, 2025, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. This call will be webcast on the Investor Relations page of the company’s website (www.unitedhealthgroup.com). The replay will be available through May 1 on the website.
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.
Optum Rx is cutting prior authorizations on 80 drugs and updating payment models to improve reimbursements, benefiting independent pharmacies nationwide.
Rising prices set by pharmaceutical companies are causing pharmacies across the United States to pay more for many drugs, impacting their ability to maintain high-quality care for patients.
